Management of early-stage Hodgkin's lymphoma: The radiation oncology experience at Northwestern University/Northwestern Memorial Hospital

Michael A. LaCombe, Bharat B Mittal*, Laura A. Colangelo, Alfred W Rademaker, William N. Brand, Harold Kim, Leo I Gordon, John M. Merrill

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Early-stage Hodgkin's lymphoma patients treated with radiotherapy alone or combined modality therapy were retrospectively analyzed for survival, patterns of failure, salvage, and toxicity. Of 75 evaluable patients, 47 were given radiotherapy alone and 28 were given combination radiotherapy and chemotherapy. Of the patients studied, 26 were clinical stage I and 49 were clinical stage II, with nine patients upstaged at laparotomy. Minimum follow- up was 2 years, with a median of 81 months. Complete response rate was 95%. Relapse-free survival and overall survival were 89% and 96%, respectively, at 2 years; 78% and 86% at 5 years; and 76% and 82% at 10 years. Of 16 patients who relapsed (21%), 13/47 patients were treated with radiotherapy and 3/28 were treated with combined modality therapy. Salvage rates were higher in those treated with radiotherapy alone. There were 13 deaths: six from disease, two from treatment-related complications, and five from second primary malignancies. There was a higher incidence of second malignancies and deaths due to complication in patients treated with combined modality therapy. Radiotherapy alone or with chemotherapy is an effective modality in the treatment of Hodgkin's lymphoma. Treatment should be selected properly to optimize results and decrease complications.

Original languageEnglish (US)
Pages (from-to)235-240
Number of pages6
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume19
Issue number3
DOIs
StatePublished - Jun 1 1996

Keywords

  • Hodgkin's disease
  • Therapeutic radiology

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Management of early-stage Hodgkin's lymphoma: The radiation oncology experience at Northwestern University/Northwestern Memorial Hospital'. Together they form a unique fingerprint.

Cite this